(R)-3-Amino-4-(4-trifluoromethylphenyl)-butyric acid hydrochloride is a chiral amino acid derivative featuring a trifluoromethylphenyl group. It serves as a crucial chiral building block in pharmaceutical synthesis. This compound is primarily recognized as a key intermediate in the synthesis of Pregabalin, a widely prescribed medication for neuropathic pain, fibromyalgia, and as an adjunct therapy for partial-onset seizures. The (R)-enantiomer is specifically utilized in certain synthetic routes to construct the pharmacologically active (S)-enantiomer of Pregabalin (Lyrica®), highlighting its importance in producing the correct stereoisomer for therapeutic efficacy. Its structural motif, combining a chiral amino acid backbone with a lipophilic, electron-withdrawing trifluoromethylphenyl group, makes it a valuable synthon for medicinal chemistry, particularly in central nervous system (CNS) drug discovery programs targeting GABA analogs.